Provided by Tiger Trade Technology Pte. Ltd.

Aethlon Medical

2.16
-0.0500-2.26%
Post-market: 2.14-0.0196-0.91%18:45 EDT
Volume:39.30K
Turnover:85.01K
Market Cap:2.84M
PE:-0.04
High:2.24
Open:2.22
Low:2.11
Close:2.21
52wk High:35.20
52wk Low:1.36
Shares:1.32M
Float Shares:1.31M
Volume Ratio:0.48
T/O Rate:3.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-48.4600
EPS(LYR):-85.7749
ROE:-208.60%
ROA:-62.88%
PB:0.42
PE(LYR):-0.03

Loading ...

Aethlon Medical Reports Q2 Cost Reduction and Ongoing Cancer Trial Progress

Reuters
·
Nov 13, 2025

Aethlon Medical Q2 EPS $(3.74) Misses $(3.66) Estimate

Benzinga
·
Nov 13, 2025

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

THOMSON REUTERS
·
Nov 13, 2025

Aethlon Medical Inc - Qtrly Loss per Share $3.74

THOMSON REUTERS
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Aethlon Medical Inc expected to post a loss of $3.66 a share - Earnings Preview

Reuters
·
Nov 08, 2025

Aethlon Medical Inc. to Report Fiscal Second Quarter Results

Reuters
·
Nov 07, 2025

Aethlon Medical Regains Nasdaq Compliance After Stock Surge

TIPRANKS
·
Nov 06, 2025

Aethlon Medical Inc - Regains Compliance With Nasdaq Minimum Bid Price - SEC Filing

THOMSON REUTERS
·
Nov 06, 2025

Aethlon Medical Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Oct 23, 2025

Aethlon Medical Faces Nasdaq Delisting After Failing Minimum Bid Price Requirement

Reuters
·
Oct 23, 2025

Aethlon Medical trading halted, news pending

TIPRANKS
·
Oct 18, 2025

Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Oct 16, 2025

Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025

Reuters
·
Oct 16, 2025

BRIEF-Aethlon Medical's Hemopurifier® Shows Changes In Extracellular Vesicles, Extracellular Micrornas, And T Cell Numbers In Australian Oncology Clinical Trial

Reuters
·
Oct 07, 2025

Aethlon Medical Announces Promising Early Data from Australian Clinical Trial of Hemopurifier® in Cancer Patients Resistant to Anti-PD-1 Therapy

Reuters
·
Oct 07, 2025